Amicus Therapeutics Inc Earnings

The next earnings date for Amicus Therapeutics Inc is November 5, 2025.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of Amicus Therapeutics Inc Earnings

Report Date	Estimated Earnings Per Share
11/05/2025	$0.02

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Amicus Therapeutics Inc Earnings: Historical

Report Date	Before/After Market	Earnings Per Share	Surprise %
07/31/2025	---	$0.01	109.01%
05/07/2025	Before Market	$0.03	142.86%
02/26/2025	Before Market	$0.09	-1.21%
11/06/2024	Before Market	$-0.02	-100.00%
08/08/2024	Before Market	$-0.05	16.67%
05/09/2024	Before Market	$-0.16	-128.57%
02/28/2024	Before Market	$-0.11	-83.33%
11/08/2023	Before Market	$-0.07	12.50%
08/08/2023	Before Market	$-0.15	-25.00%
05/10/2023	Before Market	$-0.18	-20.00%
03/01/2023	Before Market	$-0.19	-46.15%
11/07/2022	Before Market	$-0.12	36.84%
08/04/2022	Before Market	$-0.21	4.55%
05/09/2022	Before Market	$-0.30	-20.00%
02/24/2022	Before Market	$-0.29	-81.25%
11/09/2021	Before Market	$-0.19	-11.76%
08/05/2021	Before Market	$-0.19	9.52%
05/10/2021	Before Market	$-0.25	-8.70%
03/01/2021	Before Market	$-0.27	-22.73%
11/05/2020	Before Market	$-0.23	-4.55%
08/10/2020	Before Market	$-0.20	23.08%
05/07/2020	Before Market	$-0.34	-21.43%
03/02/2020	Before Market	$-0.35	-29.63%
11/11/2019	Before Market	$-0.24	25.00%
08/08/2019	Before Market	$-0.36	-9.09%
05/08/2019	Before Market	$-0.39	-25.81%
02/28/2019	Before Market	$-0.41	-46.43%
11/05/2018	Before Market	$-0.31	-10.71%
08/07/2018	Before Market	$-0.33	0.00%
05/08/2018	Before Market	$-0.28	22.22%
02/28/2018	Before Market	$-0.41	-36.67%
11/08/2017	Before Market	$-0.41	-32.26%
08/07/2017	Before Market	$-0.34	5.56%
05/09/2017	Before Market	$-0.39	-8.33%
03/01/2017	Before Market	$-0.42	-27.27%
11/07/2016	Before Market	$-0.33	-6.45%
08/09/2016	Before Market	$-0.40	-21.21%
05/03/2016	Before Market	$-0.35	-2.94%
02/26/2016	Before Market	$-0.36	-20.00%
11/03/2015	After Market	$-0.32	-28.00%
08/05/2015	After Market	$-0.26	-8.33%
05/05/2015	After Market	$-0.25	-25.00%
03/03/2015	After Market	$-0.24	-33.33%
11/06/2014	After Market	$-0.22	-4.76%
08/07/2014	---	$-0.22	4.35%
05/05/2014	---	$-0.25	-4.17%
03/03/2014	---	$-0.18	43.75%
11/12/2013	---	$-0.29	14.71%
08/07/2013	---	$-0.31	11.43%
05/09/2013	---	$-0.35	-6.06%
03/12/2013	---	$-0.20	45.95%
11/05/2012	---	$-0.34	-41.67%
08/07/2012	---	$-0.20	13.04%
05/10/2012	---	$-0.35	0.00%
02/13/2012	---	$-0.25	32.43%
11/01/2011	---	$-0.28	15.15%
08/08/2011	---	$-0.37	-15.63%
05/04/2011	---	$-0.39	-11.43%
02/14/2011	---	$-0.48	-220.00%
11/08/2010	---	$-0.56	-14.29%
08/05/2010	---	$-0.41	22.64%
05/06/2010	---	$-0.54	6.90%
02/16/2010	---	$1.45	345.76%
10/29/2009	---	$-0.59	13.24%
08/05/2009	---	$-0.60	7.69%
05/07/2009	---	$-0.55	14.06%
02/05/2009	---	$-0.63	-1.61%
11/03/2008	---	$-0.36	23.40%
08/07/2008	---	$-0.41	19.61%
05/13/2008	---	$-0.34	10.53%
01/29/2008	---	$-0.53	-32.50%
10/31/2007	---	$-0.46	0.00%
08/07/2007	---	$-1.37	-185.42%

More About Amicus Therapeutics Inc

Website

https://amicusrx.com

Country

USA

Full Time Employees

499

Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering novel medicines for rare diseases in the United States and internationally. The company's commercial product and product candidates consist of Galafold, an orally administered monotherapy for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant; and Pombiliti + Opfolda, a novel two-component treatment program for adults living with late-onset Pompe disease. It has collaboration and license agreement with GlaxoSmithKline to develop and commercialize Galafold. Amicus Therapeutics, Inc. was incorporated in 2002 and is headquartered in Princeton, New Jersey.

“Amicus Therapeutics Inc Earnings” Can Refer to the Amicus Therapeutics Inc Earnings Date

Some people say “Amicus Therapeutics Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Amicus Therapeutics Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Amicus Therapeutics Inc Stock on the Earnings Date

If you own Amicus Therapeutics Inc stock (FOLD) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Amicus Therapeutics Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Amicus Therapeutics Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Amicus Therapeutics Inc Earnings

You can contact us any time if you would like to ask questions about Amicus Therapeutics Inc earnings or anything else related to the stock market.